<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikem.org/w/index.php?action=history&amp;feed=atom&amp;title=Methazolamide</id>
	<title>Methazolamide - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikem.org/w/index.php?action=history&amp;feed=atom&amp;title=Methazolamide"/>
	<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Methazolamide&amp;action=history"/>
	<updated>2026-04-17T07:13:37Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.38.2</generator>
	<entry>
		<id>https://wikem.org/w/index.php?title=Methazolamide&amp;diff=229351&amp;oldid=prev</id>
		<title>ClaireLewis: Created page with &quot;==Administration== *Type: Carbonic anhydrase inhibitor, diuretic *Dosage Forms: *Routes of Administration: PO *Common Trade Names: Neptazane  ==Adult Dosing== *50-100mg PO...&quot;</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Methazolamide&amp;diff=229351&amp;oldid=prev"/>
		<updated>2019-09-22T18:29:53Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;==Administration== *Type: Carbonic anhydrase inhibitor, &lt;a href=&quot;/wiki/Diuretic&quot; class=&quot;mw-redirect&quot; title=&quot;Diuretic&quot;&gt;diuretic&lt;/a&gt; *Dosage Forms: *Routes of Administration: PO *Common Trade Names: Neptazane  ==Adult Dosing== *50-100mg PO...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Página nueva&lt;/b&gt;&lt;/p&gt;&lt;div&gt;==Administration==&lt;br /&gt;
*Type: Carbonic anhydrase inhibitor, [[diuretic]]&lt;br /&gt;
*Dosage Forms:&lt;br /&gt;
*Routes of Administration: PO&lt;br /&gt;
*Common Trade Names: Neptazane&lt;br /&gt;
&lt;br /&gt;
==Adult Dosing==&lt;br /&gt;
*50-100mg PO BID/TID&lt;br /&gt;
&lt;br /&gt;
==Pediatric Dosing==&lt;br /&gt;
''Safety/efficacy not established''&lt;br /&gt;
&lt;br /&gt;
==Special Populations==&lt;br /&gt;
===[[Drug pregnancy categories|Pregnancy Rating]]===&lt;br /&gt;
*C&lt;br /&gt;
&lt;br /&gt;
===Lactation risk===&lt;br /&gt;
*Not known if enters breastmilk, use caution&lt;br /&gt;
&lt;br /&gt;
===Renal Dosing===&lt;br /&gt;
*Contraindicated in severe impairment&lt;br /&gt;
&lt;br /&gt;
===Hepatic Dosing===&lt;br /&gt;
*Contraindicated in severe impairment&lt;br /&gt;
&lt;br /&gt;
==Contraindications==&lt;br /&gt;
*Allergy to class/drug&lt;br /&gt;
*Hypokalemia&lt;br /&gt;
*Hyponatremia&lt;br /&gt;
*Hyperchloremic acidosis&lt;br /&gt;
*Renal/hepatic impairment,severe&lt;br /&gt;
*Cirrhosis&lt;br /&gt;
*Adrenal insufficiency&lt;br /&gt;
*Caution in:&lt;br /&gt;
**COPD&lt;br /&gt;
**Concomitant high-dose ASA or steroid therapy&lt;br /&gt;
**Hepatic insufficiency&lt;br /&gt;
&lt;br /&gt;
==Adverse Reactions==&lt;br /&gt;
===Serious===&lt;br /&gt;
*SJS/TEN&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Common===&lt;br /&gt;
*Drowsiness&lt;br /&gt;
*Paresthesias&lt;br /&gt;
*Anorexia, nausea/vomiting&lt;br /&gt;
*Sulfonamide-type reactions&lt;br /&gt;
*Acidosis&lt;br /&gt;
*Electrolyte imbalance&lt;br /&gt;
*Glycosuria&lt;br /&gt;
*Hematuria&lt;br /&gt;
*Thrombocytopenia&lt;br /&gt;
*Hepatic dysfunction&lt;br /&gt;
*Tinnitus&lt;br /&gt;
&lt;br /&gt;
==Pharmacology==&lt;br /&gt;
*Half-life: 14d&lt;br /&gt;
*Metabolism: &lt;br /&gt;
*Excretion: Urine&lt;br /&gt;
&lt;br /&gt;
==Mechanism of Action==&lt;br /&gt;
*Carbonic anhydrase inhibitor&lt;br /&gt;
&lt;br /&gt;
==Comments==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Pharmacology]]&lt;/div&gt;</summary>
		<author><name>ClaireLewis</name></author>
	</entry>
</feed>